Cannabinoid Receptor Antagonists
Cannabinoid receptor antagonists are compounds that selectively block the action of cannabinoid receptors in the body. These receptors, particularly CB1 and CB2, are part of the endocannabinoid system, which plays a crucial role in regulating various physiological processes such as pain sensation, mood, appetite, and memory. Antagonists bind to cannabinoid receptors without activating them, thereby preventing endogenous cannabinoids (like anandamide and 2-AG) or exogenous cannabinoids (like THC) from exerting their effects. This blockade can have therapeutic implications, potentially altering pain perception, appetite regulation, and immune function. Cannabinoid receptor antagonists are being studied for their potential therapeutic uses in conditions such as obesity, addiction, pain management, and inflammatory disorders, where modulation of the endocannabinoid system may offer clinical benefits.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
Total:3 Page 1 of 1 1
